Sign up
Pharma Capital

WideCells Group hopeful of signing its first contract within weeks

WideCells Group PLC's (LON:WDC) David Sefton and John Quinlan update Proactive London's Andrew Scott following the release this week of an operational update on the business.

The company will soon become Iconic Labs PLC, taking the name of the group that joined the company in March, which marked a change of strategy for the former stem cell business.


View full WDC profile View Profile

What is social first publishing?

View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.